Trial design
The study was open-label, quasi-experimental, prospective and unicentric
study developed in a PED of a third-level Spanish hospital which
receives 58,000 emergencies annually. The study took place between June
2020 and February 2021. The trial was approved by the hospital’s
Institutional Review Board.